Lejárt a biztonsági időkorlát.
Ha az oldal űrlapot is tartalmaz, annak mentése csak érvényes bejelentkezéssel lehetséges.
A bejelentkezés érvényességének meghosszabbításához kérjük lépjen be!
Felhasználó név:
Jelszó:
 
Továbbképzések, rendezvények részletes információi
szeptember
HKSCPSV
1234567
891011121314
15161718192021
22232425262728
2930
doki.NET háttér-rendszert használó más társaságok legfrissebb hírei
• Kedves Kolléganők! Kedves Kollégák!Szeretettel üdvözlöm Önöket a Magyar Szívsebészeti Társaság XXXI. Kongresszusán.A Magyar Szívsebészeti...>> Magyar Sebész Társaság hírei
[ 2025.09.09. ]
• Tájékoztatjuk, hogy a Prima Medica 2025. október 4-én 09:00-15:45-ig a BKIK-ban (1016 Budapest, Krisztina krt. 99.)...>> Magyar Gyermekorvosok Társasága hírei
[ 2025.09.09. ]
• Az MRE-MRSZE a kongresszus keretén belül közös futásra és gyaloglásra invitálja a résztvevőket. Reggeli futás időpontja: 2025....>> Magyar Reumatológusok Egyesülete hírei
[ 2025.09.09. ]
• Kedves Kollégák, Kedves Érdeklődők!Örömmel hívjuk meg Önöket a Lóránd Sándor-napra, amely 2025. november 7-én Dunaszerdahelyen kerül...>> Magyar Pszichiátriai Társaság hírei
[ 2025.09.09. ]
• A borászat tudomány vagy művészet?Hogyan értékeljük a borokat – Kóstoljunk együtt!Prof. Dr. Botos Ernő...>> Magyar Nephrologiai Társaság hírei
[ 2025.09.09. ]
Linkek, dokumentumok oldalon belüli megjelenítése
Külön ablakban történő megjelenítés (gyorsabb!)
Kongresszusok, rendezvények
 
Ezen az oldalon hazai és nemzetközi rendezvényekről szóló információkat helyezünk el, időrendi sorrendben.

Tipp: A kongresszusokhoz különböző linkek, dokumentumok tartoz(hat)nak, melyeket a "kapcsolódó dokumentumok/linkek" feliratra kattintva érhet el. A felirat mögött zárójelben megjelenő szám a kapcsolódó anyagok számát jelöli.

Hazai kongresszusok rendezvények
[ 1 ][ 2 ][ 3 ][ 4 ][ 5 ][ 6 ][ 7 ][ 8 ][ 9 ][ 10 ]
[ 11 ][ 12 ][ 13 ][ 14 ][ 15 ][ 16 ][ 17 ][ 18 ][ 19 ][ 20 ]
[ 21 ][ 22 ][ 23 ][ 24 ][ 25 ][ 26 ][ 27 ][ 28 ][ 29 ][ 30 ]
[ 31 ][ 32 ][ 33 ][ 34 ][ 35 ][ 36 ][ 37 ][ 38 ][ 39 ][ 40 ]
[ 41 ][ 42 ][ 43 ][ 44 ][ 45 ][ 46 ][ 47 ][ 48 ][ 49 ][ 50 ]
[ 51 ][ 52 ][ 53 ][ 54 ][ 55 ][ 56 ][ 57 ][ 58 ][ 59 ][ 60 ]
[ 61 ][ 62 ][ 63 ][ 64 ][ 65 ][ 66 ][ 67 ][ 68 ][ 69 ][ 70 ]
[ 71 ][ 72 ][ 73 ][ 74 ][ 75 ][ 76 ][ 77 ][ 78 ][ 79 ][ 80 ]
[ 81 ][ 82 ][ 83 ][ 84 ][ 85 ][ 86 ][ 87 ][ 88 ][ 89 ][ 90 ]
[ 91 ][ 92 ][ 93 ][ 94 ][ 95 ][ 96 ][ 97 ][ 98 ][ 99 ][ 100 ]
[ 101 ][ 102 ][ 103 ][ 104 ][ 105 ][ 106 ][ 107 ][ 108 ][ 109 ][ 110 ]
[ 111 ][ 112 ][ 113 ][ 114 ][ 115 ][ 116 ][ 117 ][ 118 ][ 119 ][ 120 ]
[ 121 ][ 122 ][ 123 ][ 124 ][ 125 ][ 126 ][ 127 ][ 128 ][ 129 ][ 130 ]
[ 131 ][ 132 ][ 133 ][ 134 ][ 135 ][ 136 ][ 137 ][ 138 ][ 139 ][ 140 ]
[ 141 ][ 142 ][ 143 ][ 144 ][ 145 ][ 146 ][ 147 ][ 148 ][ 149 ][ 150 ]
[ 151 ][ 152 ][ 153 ][ 154 ][ 155 ][ 156 ][ 157 ][ 158 ][ 159 ][ 160 ]
[ 161 ][ 162 ][ 163 ][ 164 ][ 165 ][ 166 ][ 167 ][ 168 ][ 169 ][ 170 ]
[ 171 ][ 172 ][ 173 ][ 174 ][ 175 ][ 176 ][ 177 ][ 178 ][ 179 ][ 180 ]
[ 181 ][ 182 ][ 183 ][ 184 ][ 185 ][ 186 ][ 187 ][ 188 ][ 189 ][ 190 ]
[ 191 ][ 192 ][ 193 ][ 194 ][ 195 ][ 196 ][ 197 ][ 198 ][ 199 ][ 200 ]
[ 201 ][ 202 ][ 203 ][ 204 ][ 205 ][ 206 ][ 207 ][ 208 ][ 209 ][ 210 ]
[ 211 ][ 212 ][ 213 ][ 214 ][ 215 ][ 216 ][ 217 ][ 218 ][ 219 ][ 220 ]
[ 221 ][ 222 ][ 223 ][ 224 ][ 225 ][ 226 ][ 227 ][ 228 ][ 229 ][ 230 ]
[ 231 ][ 232 ][ 233 ][ 234 ][ 235 ][ 236 ][ 237 ][ 238 ][ 239 ][ 240 ]
[ 241 ][ 242 ][ 243 ][ 244 ][ 245 ][ 246 ][ 247 ][ 248 ][ 249 ][ 250 ]
[ 251 ][ 252 ][ 253 ][ 254 ][ 255 ][ 256 ][ 257 ][ 258 ][ 259 ][ 260 ]
[ 261 ][ 262 ][ 263 ][ 264 ][ 265 ][ 266 ][ 267 ][ 268 ][ 269 ][ 270 ]
[ 271 ][ 272 ][ 273 ][ 274 ][ 275 ][ 276 ][ 277 ][ 278 ][ 279 ][ 280 ]
[ 281 ][ 282 ][ 283 ][ 284 ][ 285 ][ 286 ][ 287 ][ 288 ][ 289 ][ 290 ]
[ 291 ][ 292 ][ 293 ][ 294 ][ 295 ][ 296 ][ 297 ][ 298 ][ 299 ][ 300 ]
[ 301 ][ 302 ][ 303 ][ 304 ][ 305 ][ 306 ][ 307 ][ 308 ][ 309 ][ 310 ]
[ 311 ][ 312 ][ 313 ][ 314 ][ 315 ][ 316 ][ 317 ][ 318 ][ 319 ][ 320 ]
[ 321 ][ 322 ][ 323 ][ 324 ][ 325 ][ 326 ][ 327 ][ 328 ][ 329 ][ 330 ]
[ 331 ][ 332 ][ 333 ][ 334 ][ 335 ][ 336 ][ 337 ][ 338 ][ 339 ][ 340 ]
[ 341 ][ 342 ][ 343 ][ 344 ][ 345 ][ 346 ][ 347 ][ 348 ][ 349 ][ 350 ]
[ 351 ][ 352 ][ 353 ][ 354 ][ 355 ][ 356 ][ 357 ][ 358 ][ 359 ][ 360 ]
[ 361 ][ 362 ][ 363 ][ 364 ][ 365 ][ 366 ][ 367 ][ 368 ][ 369 ][ 370 ]
[ 371 ][ 372 ][ 373 ][ 374 ][ 375 ][ 376 ][ 377 ][ 378 ][ 379 ][ 380 ]
[ 381 ][ 382 ][ 383 ][ 384 ][ 385 ][ 386 ][ 387 ][ 388 ][ 389 ][ 390 ]
[ 391 ][ 392 ][ 393 ][ 394 ][ 395 ][ 396 ][ 397 ][ 398 ][ 399 ][ 400 ]
[ 401 ][ 402 ][ 403 ][ 404 ][ 405 ][ 406 ][ 407 ][ 408 ][ 409 ][ 410 ]
[ 411 ][ 412 ][ 413 ][ 414 ][ 415 ][ 416 ][ 417 ][ 418 ][ 419 ][ 420 ]
[ 421 ][ 422 ][ 423 ][ 424 ][ 425 ][ 426 ][ 427 ][ 428 ][ 429 ][ 430 ]
[ 431 ][ 432 ][ 433 ][ 434 ][ 435 ][ 436 ][ 437 ][ 438 ][ 439 ][ 440 ]
[ 441 ][ 442 ][ 443 ][ 444 ][ 445 ][ 446 ][ 447 ][ 448 ][ 449 ][ 450 ]
[ 451 ][ 452 ][ 453 ][ 454 ][ 455 ][ 456 ][ 457 ][ 458 ][ 459 ][ 460 ]
[ 461 ][ 462 ][ 463 ][ 464 ][ 465 ][ 466 ][ 467 ][ 468 ][ 469 ][ 470 ]
[ 471 ][ 472 ][ 473 ][ 474 ][ 475 ][ 476 ][ 477 ][ 478 ][ 479 ][ 480 ]
[ 481 ][ 482 ][ 483 ][ 484 ][ 485 ][ 486 ][ 487 ][ 488 ][ 489 ][ 490 ]
[ 491 ][ 492 ][ 493 ][ 494 ][ 495 ][ 496 ][ 497 ][ 498 ][ 499 ][ 500 ]
[ 501 ][ 502 ][ 503 ][ 504 ][ 505 ][ 506 ][ 507 ][ 508 ][ 509 ][ 510 ]
[ 511 ][ 512 ][ 513 ][ 514 ][ 515 ][ 516 ][ 517 ][ 518 ][ 519 ][ 520 ]
[ 521 ][ 522 ][ 523 ][ 524 ][ 525 ][ 526 ][ 527 ][ 528 ][ 529 ][ 530 ]
[ 531 ][ 532 ][ 533 ][ 534 ][ 535 ][ 536 ][ 537 ][ 538 ][ 539 ][ 540 ]
[ 541 ][ 542 ][ 543 ][ 544 ][ 545 ][ 546 ][ 547 ][ 548 ][ 549 ][ 550 ]
[ 551 ][ 552 ][ 553 ][ 554 ][ 555 ][ 556 ][ 557 ][ 558 ][ 559 ][ 560 ]
[ 561 ][ 562 ][ 563 ][ 564 ][ 565 ][ 566 ][ 567 ][ 568 ][ 569 ][ 570 ]
[ 571 ][ 572 ][ 573 ][ 574 ][ 575 ][ 576 ][ 577 ][ 578 ][ 579 ][ 580 ]
[ 581 ][ 582 ][ 583 ][ 584 ][ 585 ][ 586 ][ 587 ][ 588 ][ 589 ][ 590 ]
[ 591 ][ 592 ][ 593 ][ 594 ][ 595 ][ 596 ][ 597 ][ 598 ][ 599 ][ 600 ]
[ 601 ][ 602 ][ 603 ][ 604 ][ 605 ][ 606 ][ 607 ][ 608 ][ 609 ][ 610 ]
[ 611 ][ 612 ][ 613 ][ 614 ][ 615 ][ 616 ][ 617 ][ 618 ][ 619 ][ 620 ]
[ 621 ][ 622 ][ 623 ][ 624 ][ 625 ][ 626 ][ 627 ][ 628 ][ 629 ][ 630 ]
[ 631 ][ 632 ][ 633 ][ 634 ][ 635 ][ 636 ][ 637 ][ 638 ][ 639 ][ 640 ]
[ 641 ][ 642 ][ 643 ][ 644 ][ 645 ][ 646 ][ 647 ][ 648 ][ 649 ][ 650 ]
[ 651 ][ 652 ][ 653 ][ 654 ][ 655 ][ 656 ][ 657 ][ 658 ][ 659 ][ 660 ]
[ 661 ][ 662 ][ 663 ][ 664 ][ 665 ][ 666 ][ 667 ][ 668 ][ 669 ][ 670 ]
[ 671 ][ 672 ][ 673 ][ 674 ][ 675 ][ 676 ][ 677 ][ 678 ][ 679 ][ 680 ]
[ 681 ][ 682 ][ 683 ][ 684 ][ 685 ][ 686 ][ 687 ][ 688 ][ 689 ][ 690 ]
[ 691 ][ 692 ][ 693 ][ 694 ][ 695 ][ 696 ][ 697 ][ 698 ][ 699 ][ 700 ]
[ 701 ][ 702 ][ 703 ][ 704 ][ 705 ][ 706 ][ 707 ][ 708 ][ 709 ][ 710 ]
[ 711 ][ 712 ][ 713 ][ 714 ][ 715 ][ 716 ][ 717 ][ 718 ][ 719 ][ 720 ]
[ 721 ][ 722 ][ 723 ][ 724 ][ 725 ][ 726 ][ 727 ][ 728 ][ 729 ][ 730 ]
[ 731 ][ 732 ][ 733 ][ 734 ][ 735 ][ 736 ][ 737 ][ 738 ][ 739 ][ 740 ]
[ 741 ][ 742 ][ 743 ][ 744 ][ 745 ][ 746 ][ 747 ][ 748 ][ 749 ][ 750 ]
[ 751 ][ 752 ][ 753 ][ 754 ][ 755 ][ 756 ][ 757 ][ 758 ][ 759 ][ 760 ]
[ 761 ][ 762 ][ 763 ][ 764 ][ 765 ][ 766 ][ 767 ][ 768 ][ 769 ][ 770 ]
[ 771 ][ 772 ][ 773 ][ 774 ][ 775 ][ 776 ][ 777 ][ 778 ][ 779 ][ 780 ]
[ 781 ][ 782 ][ 783 ][ 784 ][ 785 ][ 786 ][ 787 ][ 788 ][ 789 ][ 790 ]
[ 791 ][ 792 ][ 793 ][ 794 ][ 795 ][ 796 ][ 797 ][ 798 ][ 799 ][ 800 ]
[ 801 ][ 802 ][ 803 ][ 804 ][ 805 ][ 806 ][ 807 ][ 808 ][ 809 ][ 810 ]
[ 811 ][ 812 ][ 813 ][ 814 ][ 815 ][ 816 ][ 817 ][ 818 ][ 819 ][ 820 ]
[ 821 ][ 822 ][ 823 ][ 824 ][ 825 ][ 826 ][ 827 ][ 828 ][ 829 ][ 830 ]
[ 831 ][ 832 ][ 833 ][ 834 ][ 835 ][ 836 ][ 837 ][ 838 ][ 839 ][ 840 ]
[ 841 ][ 842 ][ 843 ][ 844 ][ 845 ][ 846 ][ 847 ][ 848 ][ 849 ][ 850 ]
[ 851 ][ 852 ][ 853 ][ 854 ][ 855 ][ 856 ][ 857 ][ 858 ][ 859 ][ 860 ]
[ 861 ][ 862 ][ 863 ][ 864 ][ 865 ][ 866 ][ 867 ][ 868 ][ 869 ][ 870 ]
[ 871 ][ 872 ][ 873 ][ 874 ][ 875 ][ 876 ][ 877 ][ 878 ][ 879 ][ 880 ]
[ 881 ][ 882 ][ 883 ][ 884 ][ 885 ][ 886 ][ 887 ][ 888 ][ 889 ][ 890 ]
[ 891 ][ 892 ][ 893 ][ 894 ][ 895 ][ 896 ][ 897 ][ 898 ][ 899 ][ 900 ]
[ 901 ][ 902 ][ 903 ][ 904 ][ 905 ][ 906 ][ 907 ][ 908 ][ 909 ][ 910 ]
[ 911 ][ 912 ][ 913 ][ 914 ][ 915 ][ 916 ][ 917 ][ 918 ][ 919 ][ 920 ]
[ 921 ][ 922 ][ 923 ][ 924 ][ 925 ][ 926 ][ 927 ][ 928 ][ 929 ][ 930 ]
[ 931 ][ 932 ][ 933 ][ 934 ][ 935 ][ 936 ][ 937 ][ 938 ][ 939 ][ 940 ]
[ 941 ][ 942 ][ 943 ][ 944 ][ 945 ][ 946 ][ 947 ][ 948 ][ 949 ][ 950 ]
[ 951 ][ 952 ][ 953 ][ 954 ][ 955 ][ 956 ][ 957 ][ 958 ][ 959 ][ 960 ]
[ 961 ][ 962 ][ 963 ][ 964 ][ 965 ][ 966 ][ 967 ][ 968 ][ 969 ][ 970 ]
[ 971 ][ 972 ][ 973 ][ 974 ][ 975 ][ 976 ][ 977 ][ 978 ][ 979 ][ 980 ]
[ 981 ][ 982 ][ 983 ][ 984 ][ 985 ][ 986 ][ 987 ][ 988 ][ 989 ][ 990 ]
[ 991 ][ 992 ][ 993 ][ 994 ][ 995 ][ 996 ][ 997 ][ 998 ][ 999 ][ 1000 ]
[ 1001 ][ 1002 ][ 1003 ][ 1004 ][ 1005 ][ 1006 ][ 1007 ][ 1008 ][ 1009 ][ 1010 ]
[ 1011 ][ 1012 ][ 1013 ][ 1014 ][ 1015 ][ 1016 ][ 1017 ][ 1018 ][ 1019 ][ 1020 ]
[ 1021 ][ 1022 ][ 1023 ][ 1024 ][ 1025 ][ 1026 ][ 1027 ][ 1028 ][ 1029 ][ 1030 ]
[ 1031 ][ 1032 ][ 1033 ][ 1034 ][ 1035 ][ 1036 ][ 1037 ][ 1038 ][ 1039 ][ 1040 ]
[ 1041 ][ 1042 ][ 1043 ][ 1044 ][ 1045 ][ 1046 ][ 1047 ][ 1048 ][ 1049 ][ 1050 ]
[ 1051 ][ 1052 ][ 1053 ][ 1054 ][ 1055 ][ 1056 ][ 1057 ][ 1058 ][ 1059 ][ 1060 ]
[ 1061 ][ 1062 ][ 1063 ][ 1064 ][ 1065 ][ 1066 ][ 1067 ][ 1068 ][ 1069 ][ 1070 ]
[ 1071 ][ 1072 ][ 1073 ][ 1074 ][ 1075 ][ 1076 ][ 1077 ][ 1078 ][ 1079 ][ 1080 ]
[ 1081 ][ 1082 ][ 1083 ][ 1084 ][ 1085 ][ 1086 ][ 1087 ][ 1088 ][ 1089 ][ 1090 ]
[ 1091 ][ 1092 ][ 1093 ][ 1094 ][ 1095 ][ 1096 ][ 1097 ][ 1098 ][ 1099 ][ 1100 ]
[ 1101 ][ 1102 ][ 1103 ][ 1104 ][ 1105 ][ 1106 ][ 1107 ][ 1108 ][ 1109 ][ 1110 ]
[ 1111 ][ 1112 ][ 1113 ][ 1114 ][ 1115 ][ 1116 ][ 1117 ][ 1118 ][ 1119 ][ 1120 ]
[ 1121 ][ 1122 ][ 1123 ][ 1124 ][ 1125 ][ 1126 ][ 1127 ][ 1128 ][ 1129 ][ 1130 ]
[ 1131 ][ 1132 ][ 1133 ][ 1134 ][ 1135 ][ 1136 ][ 1137 ][ 1138 ][ 1139 ][ 1140 ]
[ 1141 ][ 1142 ][ 1143 ][ 1144 ][ 1145 ][ 1146 ][ 1147 ][ 1148 ][ 1149 ][ 1150 ]
[ 1151 ][ 1152 ][ 1153 ][ 1154 ][ 1155 ][ 1156 ][ 1157 ][ 1158 ][ 1159 ][ 1160 ]
[ 1161 ][ 1162 ][ 1163 ][ 1164 ][ 1165 ][ 1166 ][ 1167 ][ 1168 ][ 1169 ][ 1170 ]
[ 1171 ][ 1172 ][ 1173 ][ 1174 ][ 1175 ][ 1176 ][ 1177 ][ 1178 ][ 1179 ][ 1180 ]
[ 1181 ][ 1182 ][ 1183 ][ 1184 ][ 1185 ][ 1186 ][ 1187 ][ 1188 ][ 1189 ][ 1190 ]
[ 1191 ][ 1192 ][ 1193 ][ 1194 ][ 1195 ][ 1196 ][ 1197 ][ 1198 ][ 1199 ][ 1200 ]
[ 1201 ][ 1202 ][ 1203 ][ 1204 ][ 1205 ][ 1206 ][ 1207 ][ 1208 ][ 1209 ][ 1210 ]
[ 1211 ][ 1212 ][ 1213 ][ 1214 ][ 1215 ][ 1216 ][ 1217 ][ 1218 ][ 1219 ][ 1220 ]
[ 1221 ][ 1222 ][ 1223 ][ 1224 ][ 1225 ][ 1226 ][ 1227 ][ 1228 ][ 1229 ][ 1230 ]
[ 1231 ][ 1232 ][ 1233 ][ 1234 ][ 1235 ][ 1236 ][ 1237 ][ 1238 ][ 1239 ][ 1240 ]
[ 1241 ][ 1242 ][ 1243 ][ 1244 ][ 1245 ][ 1246 ][ 1247 ][ 1248 ][ 1249 ][ 1250 ]
[ 1251 ][ 1252 ][ 1253 ][ 1254 ][ 1255 ][ 1256 ][ 1257 ][ 1258 ][ 1259 ][ 1260 ]
[ 1261 ][ 1262 ][ 1263 ][ 1264 ][ 1265 ][ 1266 ][ 1267 ][ 1268 ][ 1269 ][ 1270 ]
[ 1271 ][ 1272 ][ 1273 ][ 1274 ][ 1275 ][ 1276 ][ 1277 ][ 1278 ][ 1279 ][ 1280 ]
[ 1281 ][ 1282 ][ 1283 ][ 1284 ][ 1285 ][ 1286 ][ 1287 ][ 1288 ][ 1289 ][ 1290 ]
[ 1291 ][ 1292 ][ 1293 ][ 1294 ][ 1295 ][ 1296 ][ 1297 ][ 1298 ][ 1299 ][ 1300 ]
[ 1301 ][ 1302 ][ 1303 ][ 1304 ][ 1305 ][ 1306 ][ 1307 ][ 1308 ][ 1309 ][ 1310 ]
[ 1311 ][ 1312 ][ 1313 ][ 1314 ][ 1315 ][ 1316 ][ 1317 ][ 1318 ][ 1319 ][ 1320 ]
[ 1321 ][ 1322 ][ 1323 ][ 1324 ][ 1325 ][ 1326 ][ 1327 ][ 1328 ][ 1329 ][ 1330 ]
[ 1331 ][ 1332 ][ 1333 ][ 1334 ][ 1335 ][ 1336 ][ 1337 ][ 1338 ][ 1339 ][ 1340 ]
[ 1341 ][ 1342 ][ 1343 ][ 1344 ][ 1345 ][ 1346 ][ 1347 ][ 1348 ][ 1349 ][ 1350 ]
[ 1351 ][ 1352 ][ 1353 ][ 1354 ][ 1355 ][ 1356 ][ 1357 ][ 1358 ][ 1359 ][ 1360 ]
[ 1361 ][ 1362 ][ 1363 ][ 1364 ][ 1365 ][ 1366 ][ 1367 ][ 1368 ][ 1369 ][ 1370 ]
[ 1371 ][ 1372 ][ 1373 ][ 1374 ][ 1375 ][ 1376 ][ 1377 ][ 1378 ][ 1379 ][ 1380 ]
[ 1381 ][ 1382 ][ 1383 ][ 1384 ][ 1385 ][ 1386 ][ 1387 ][ 1388 ][ 1389 ][ 1390 ]
[ 1391 ][ 1392 ][ 1393 ][ 1394 ][ 1395 ][ 1396 ][ 1397 ][ 1398 ][ 1399 ][ 1400 ]
[ 1401 ][ 1402 ][ 1403 ][ 1404 ][ 1405 ][ 1406 ][ 1407 ][ 1408 ][ 1409 ][ 1410 ]
[ 1411 ][ 1412 ][ 1413 ][ 1414 ][ 1415 ][ 1416 ][ 1417 ][ 1418 ][ 1419 ][ 1420 ]
[ 1421 ][ 1422 ][ 1423 ][ 1424 ][ 1425 ][ 1426 ][ 1427 ][ 1428 ][ 1429 ][ 1430 ]
[ 1431 ][ 1432 ][ 1433 ][ 1434 ][ 1435 ][ 1436 ][ 1437 ][ 1438 ][ 1439 ][ 1440 ]
[ 1441 ][ 1442 ][ 1443 ][ 1444 ][ 1445 ][ 1446 ][ 1447 ][ 1448 ][ 1449 ][ 1450 ]
[ 1451 ][ 1452 ][ 1453 ][ 1454 ][ 1455 ][ 1456 ][ 1457 ][ 1458 ][ 1459 ][ 1460 ]
[ 1461 ][ 1462 ][ 1463 ][ 1464 ][ 1465 ][ 1466 ][ 1467 ][ 1468 ][ 1469 ][ 1470 ]
[ 1471 ][ 1472 ][ 1473 ][ 1474 ][ 1475 ][ 1476 ][ 1477 ][ 1478 ][ 1479 ][ 1480 ]
[ 1481 ][ 1482 ][ 1483 ][ 1484 ][ 1485 ][ 1486 ][ 1487 ][ 1488 ][ 1489 ][ 1490 ]
[ 1491 ][ 1492 ][ 1493 ][ 1494 ][ 1495 ][ 1496 ][ 1497 ][ 1498 ][ 1499 ][ 1500 ]
[ 1501 ][ 1502 ][ 1503 ][ 1504 ][ 1505 ][ 1506 ][ 1507 ][ 1508 ][ 1509 ][ 1510 ]
[ 1511 ][ 1512 ][ 1513 ][ 1514 ][ 1515 ][ 1516 ][ 1517 ][ 1518 ][ 1519 ][ 1520 ]
[ 1521 ][ 1522 ][ 1523 ][ 1524 ][ 1525 ][ 1526 ][ 1527 ][ 1528 ][ 1529 ][ 1530 ]
[ 1531 ][ 1532 ][ 1533 ][ 1534 ][ 1535 ][ 1536 ][ 1537 ][ 1538 ][ 1539 ][ 1540 ]
[ 1541 ][ 1542 ][ 1543 ][ 1544 ][ 1545 ][ 1546 ][ 1547 ][ 1548 ][ 1549 ][ 1550 ]
[ 1551 ][ 1552 ][ 1553 ][ 1554 ][ 1555 ][ 1556 ][ 1557 ][ 1558 ][ 1559 ][ 1560 ]
[ 1561 ][ 1562 ][ 1563 ][ 1564 ][ 1565 ][ 1566 ][ 1567 ][ 1568 ][ 1569 ][ 1570 ]
[ 1571 ][ 1572 ][ 1573 ][ 1574 ][ 1575 ][ 1576 ][ 1577 ][ 1578 ][ 1579 ][ 1580 ]
[ 1581 ][ 1582 ][ 1583 ][ 1584 ][ 1585 ][ 1586 ][ 1587 ][ 1588 ][ 1589 ][ 1590 ]
[ 1591 ][ 1592 ][ 1593 ][ 1594 ][ 1595 ][ 1596 ][ 1597 ][ 1598 ][ 1599 ][ 1600 ]
[ 1601 ][ 1602 ][ 1603 ][ 1604 ][ 1605 ][ 1606 ][ 1607 ][ 1608 ][ 1609 ][ 1610 ]
[ 1611 ][ 1612 ][ 1613 ][ 1614 ][ 1615 ][ 1616 ][ 1617 ][ 1618 ][ 1619 ][ 1620 ]
[ 1621 ][ 1622 ][ 1623 ][ 1624 ][ 1625 ][ 1626 ][ 1627 ][ 1628 ][ 1629 ][ 1630 ]
[ 1631 ][ 1632 ][ 1633 ][ 1634 ][ 1635 ][ 1636 ][ 1637 ][ 1638 ][ 1639 ][ 1640 ]
[ 1641 ][ 1642 ][ 1643 ][ 1644 ][ 1645 ][ 1646 ][ 1647 ][ 1648 ][ 1649 ][ 1650 ]
[ 1651 ][ 1652 ][ 1653 ][ 1654 ][ 1655 ][ 1656 ][ 1657 ][ 1658 ][ 1659 ][ 1660 ]
[ 1661 ][ 1662 ][ 1663 ][ 1664 ][ 1665 ][ 1666 ][ 1667 ][ 1668 ][ 1669 ][ 1670 ]
 
Magyar Dermatológiai Társulat Szakdolgozói Munkacsoportja
Magyar Sebkezelő Társaság XXVI. Kongresszusa (Budapest, 2024.10.17-18.)
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2024.10.17.Rendezvény vége: 2024.10.18.
Helyszín: 1068 Budapest, Benczúr u. 35., Hotel Benczúr
A rendezvény Web oldala: http://www.etalon95.hu/mskt/kongresszus/index.html
Online előadás-bejelentés: http://www.etalon95.hu/mskt/kongresszus/eloadas-bejelentes.html

Szervező Bizottság: Dr. Farkas Péter, Hanga Péter, Prof. Dr. Hunyadi János, Prof. Dr. Juhász István, Dr. Kovács L. András, Dr. Sugár István

Ebben az évben fő témákat nem adunk meg. Az előadást tartó szakdolgozók részvétele ingyenes.
 
Magyar Nephrologiai Társaság
IV. Életmódorvosi Konferencia
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2024.10.10.Rendezvény vége: 2024.10.12.
Helyszín: 8380 Hévíz, Attila u. 1., NaturMed Hotel Carbona Superior****
A rendezvény Web oldala: https://www.emot.hu/eletmodorvosi-konferencia-2024
Tisztelettel meghívjuk Önt a IV. Életmódorvosi Konferenciára, amelyet idén október 10-12. között rendezünk Hévízen.

Ez az esemény a Magyar Életmód Orvostani Társaság (ÉMOT) éves szakmai találkozója, melynek fő célja az életmódorvoslással kapcsolatos legfrissebb kutatási eredmények megismerése, a szakmai előrehaladás elősegítése, valamint az életmóddal kapcsolatos innovatív kezelési stratégiák és módszerek megvitatása.

A konferencia egyben a Mozgás Receptre program szakmai konferenciája is. A program lényege, hogy a mozgást, fizikai aktivitást (házi)orvosok ajánlják, írják fel receptre, mint megelőző és gyógyító eszközt. Az egészségben eltöltött életévek száma növekedhet azáltal, hogy növeljük a lakosság fizikai aktivitását, mozgással töltött idejét. A fizikai aktivitás növelése mozgásprogramokon, sportklubokban valósul meg. A ,,Mozgás Receptre” program ezáltal hidat, kapcsot képez az egészségügyi szektor és a mozgás-, sportszektor között.

Konferencia időpontja: 2024. október 10-12.

Helyszín:
 NaturMed Hotel Carbona Superior**** (8380 Hévíz, Attila u. 1.)

Fontos dátumok:
  • Absztrakt beküldési határideje: 2024. 06. 30.
    • Az absztrakt felhívást és az absztrakt leadáshoz szükséges sablont itt találja.
  • “Early Bird” regisztráció határideje: 2024.07.31.

Jelentkezés:
  • E-mail-en: konferencia2024@emot.hu jelentkezési lappal.
  • Telefonon: +36 141 4228
  • Céges és csoportos regisztráció esetén kérjük jelentkezzenek a konferencia szervezés elérhetőségein.

Rendezvényszervezés:
A konferencia hivatalos oldala: www.emot.hu/eletmodorvosi-konferencia-2024
 
Magyar Radiológusok Társasága
Multimodális képalkotó diagnosztika szerepe az onkológiában tanfolyam
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2024.10.09.Rendezvény vége: 2024.10.11.
Helyszín: Budapest, Országos Onkológiai Intézet
2024.10.09-11. közt szervezzük meg a Multimodális képalkotó diagnosztika szerepe az onkológiában c. tanfolyamot az Országos Onkológiai Intézetben, melyre még 09.25-ig lehet az OFTEX-en jelentkezni.

Várunk minden érdeklődőt szeretettel.

A program megtekinthető ide kattintva
 
Magyar Radiológusok Társasága
Multimodális képalkotó diagnosztika szerepe az onkológiában tanfolyam
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2024.10.09.Rendezvény vége: 2024.10.11.
Helyszín: Budapest, Országos Onkológiai Intézet
2024.10.09-11. közt szervezzük meg a Multimodális képalkotó diagnosztika szerepe az onkológiában c. tanfolyamot az Országos Onkológiai Intézetben, melyre még 09.25-ig lehet az OFTEX-en jelentkezni.

Várunk minden érdeklődőt szeretettel.

A program megtekinthető ide kattintva
 
Magyar Radiológusok Társasága
Multimodális képalkotó diagnosztika szerepe az onkológiában tanfolyam
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2024.10.09.Rendezvény vége: 2024.10.11.
Helyszín: Budapest, Országos Onkológiai Intézet
2024.10.09-11. közt szervezzük meg a Multimodális képalkotó diagnosztika szerepe az onkológiában c. tanfolyamot az Országos Onkológiai Intézetben, melyre még 09.25-ig lehet az OFTEX-en jelentkezni.

Várunk minden érdeklődőt szeretettel.

A program megtekinthető ide kattintva

Külföldi kongresszusok rendezvények
[ 1 ][ 2 ][ 3 ][ 4 ][ 5 ][ 6 ][ 7 ][ 8 ][ 9 ][ 10 ]
[ 11 ][ 12 ][ 13 ][ 14 ][ 15 ][ 16 ][ 17 ][ 18 ][ 19 ][ 20 ]
[ 21 ][ 22 ][ 23 ][ 24 ][ 25 ][ 26 ][ 27 ][ 28 ][ 29 ][ 30 ]
[ 31 ][ 32 ][ 33 ][ 34 ][ 35 ][ 36 ][ 37 ][ 38 ][ 39 ][ 40 ]
[ 41 ][ 42 ][ 43 ][ 44 ][ 45 ][ 46 ][ 47 ][ 48 ][ 49 ][ 50 ]
[ 51 ][ 52 ][ 53 ][ 54 ][ 55 ][ 56 ][ 57 ][ 58 ][ 59 ][ 60 ]
[ 61 ][ 62 ][ 63 ][ 64 ][ 65 ][ 66 ][ 67 ][ 68 ][ 69 ][ 70 ]
[ 71 ][ 72 ][ 73 ][ 74 ][ 75 ][ 76 ][ 77 ][ 78 ][ 79 ][ 80 ]
[ 81 ][ 82 ][ 83 ][ 84 ][ 85 ][ 86 ][ 87 ][ 88 ][ 89 ][ 90 ]
[ 91 ][ 92 ][ 93 ][ 94 ][ 95 ][ 96 ][ 97 ][ 98 ][ 99 ][ 100 ]
[ 101 ][ 102 ][ 103 ][ 104 ][ 105 ][ 106 ][ 107 ][ 108 ][ 109 ][ 110 ]
[ 111 ][ 112 ][ 113 ][ 114 ][ 115 ][ 116 ][ 117 ][ 118 ][ 119 ][ 120 ]
[ 121 ][ 122 ][ 123 ][ 124 ][ 125 ][ 126 ][ 127 ][ 128 ][ 129 ][ 130 ]
[ 131 ][ 132 ][ 133 ][ 134 ][ 135 ][ 136 ][ 137 ][ 138 ][ 139 ][ 140 ]
[ 141 ][ 142 ][ 143 ][ 144 ][ 145 ][ 146 ][ 147 ][ 148 ][ 149 ][ 150 ]
[ 151 ][ 152 ][ 153 ][ 154 ][ 155 ][ 156 ][ 157 ][ 158 ][ 159 ][ 160 ]
[ 161 ][ 162 ][ 163 ][ 164 ][ 165 ][ 166 ][ 167 ][ 168 ][ 169 ][ 170 ]
[ 171 ][ 172 ][ 173 ][ 174 ][ 175 ][ 176 ][ 177 ][ 178 ][ 179 ][ 180 ]
[ 181 ][ 182 ][ 183 ][ 184 ][ 185 ][ 186 ][ 187 ][ 188 ][ 189 ][ 190 ]
[ 191 ][ 192 ][ 193 ][ 194 ][ 195 ][ 196 ][ 197 ][ 198 ][ 199 ][ 200 ]
[ 201 ][ 202 ][ 203 ][ 204 ][ 205 ][ 206 ][ 207 ][ 208 ][ 209 ][ 210 ]
[ 211 ][ 212 ][ 213 ][ 214 ][ 215 ][ 216 ][ 217 ][ 218 ][ 219 ][ 220 ]
[ 221 ][ 222 ][ 223 ][ 224 ][ 225 ][ 226 ][ 227 ][ 228 ][ 229 ][ 230 ]
[ 231 ][ 232 ][ 233 ][ 234 ][ 235 ][ 236 ][ 237 ][ 238 ][ 239 ][ 240 ]
[ 241 ][ 242 ][ 243 ][ 244 ][ 245 ][ 246 ][ 247 ][ 248 ][ 249 ][ 250 ]
[ 251 ][ 252 ][ 253 ][ 254 ][ 255 ][ 256 ][ 257 ][ 258 ][ 259 ][ 260 ]
[ 261 ][ 262 ][ 263 ][ 264 ][ 265 ][ 266 ][ 267 ][ 268 ][ 269 ][ 270 ]
[ 271 ][ 272 ][ 273 ][ 274 ][ 275 ][ 276 ][ 277 ][ 278 ][ 279 ][ 280 ]
[ 281 ][ 282 ][ 283 ][ 284 ][ 285 ][ 286 ][ 287 ][ 288 ][ 289 ][ 290 ]
[ 291 ][ 292 ][ 293 ][ 294 ][ 295 ][ 296 ][ 297 ][ 298 ][ 299 ][ 300 ]
[ 301 ][ 302 ][ 303 ][ 304 ][ 305 ][ 306 ][ 307 ][ 308 ][ 309 ][ 310 ]
[ 311 ][ 312 ][ 313 ][ 314 ][ 315 ][ 316 ][ 317 ][ 318 ][ 319 ][ 320 ]
[ 321 ][ 322 ][ 323 ][ 324 ][ 325 ][ 326 ][ 327 ][ 328 ][ 329 ][ 330 ]
[ 331 ][ 332 ][ 333 ][ 334 ][ 335 ][ 336 ][ 337 ][ 338 ][ 339 ][ 340 ]
[ 341 ][ 342 ][ 343 ][ 344 ][ 345 ][ 346 ][ 347 ][ 348 ][ 349 ][ 350 ]
[ 351 ][ 352 ][ 353 ][ 354 ][ 355 ][ 356 ][ 357 ][ 358 ][ 359 ][ 360 ]
[ 361 ][ 362 ][ 363 ][ 364 ][ 365 ][ 366 ][ 367 ][ 368 ][ 369 ][ 370 ]
[ 371 ][ 372 ][ 373 ][ 374 ][ 375 ][ 376 ][ 377 ][ 378 ][ 379 ][ 380 ]
[ 381 ][ 382 ][ 383 ][ 384 ][ 385 ][ 386 ][ 387 ][ 388 ][ 389 ][ 390 ]
[ 391 ][ 392 ][ 393 ][ 394 ][ 395 ][ 396 ][ 397 ][ 398 ][ 399 ][ 400 ]
[ 401 ][ 402 ][ 403 ][ 404 ][ 405 ][ 406 ][ 407 ][ 408 ][ 409 ][ 410 ]
[ 411 ][ 412 ][ 413 ][ 414 ][ 415 ][ 416 ][ 417 ][ 418 ][ 419 ][ 420 ]
[ 421 ][ 422 ][ 423 ][ 424 ][ 425 ][ 426 ][ 427 ][ 428 ][ 429 ][ 430 ]
[ 431 ][ 432 ][ 433 ][ 434 ][ 435 ][ 436 ][ 437 ][ 438 ][ 439 ][ 440 ]
[ 441 ][ 442 ][ 443 ][ 444 ][ 445 ][ 446 ][ 447 ][ 448 ][ 449 ][ 450 ]
[ 451 ][ 452 ][ 453 ][ 454 ][ 455 ][ 456 ][ 457 ][ 458 ][ 459 ][ 460 ]
[ 461 ][ 462 ][ 463 ][ 464 ][ 465 ][ 466 ][ 467 ][ 468 ][ 469 ][ 470 ]
[ 471 ][ 472 ][ 473 ][ 474 ][ 475 ][ 476 ][ 477 ][ 478 ][ 479 ][ 480 ]
[ 481 ][ 482 ][ 483 ][ 484 ][ 485 ][ 486 ][ 487 ][ 488 ][ 489 ][ 490 ]
[ 491 ][ 492 ][ 493 ][ 494 ][ 495 ][ 496 ][ 497 ][ 498 ][ 499 ][ 500 ]
[ 501 ][ 502 ][ 503 ][ 504 ][ 505 ][ 506 ][ 507 ][ 508 ][ 509 ][ 510 ]
[ 511 ][ 512 ][ 513 ][ 514 ][ 515 ][ 516 ][ 517 ][ 518 ][ 519 ][ 520 ]
[ 521 ][ 522 ][ 523 ][ 524 ][ 525 ][ 526 ][ 527 ][ 528 ][ 529 ][ 530 ]
[ 531 ][ 532 ][ 533 ][ 534 ][ 535 ][ 536 ][ 537 ][ 538 ][ 539 ][ 540 ]
[ 541 ][ 542 ][ 543 ][ 544 ][ 545 ][ 546 ][ 547 ][ 548 ][ 549 ][ 550 ]
[ 551 ][ 552 ][ 553 ][ 554 ][ 555 ][ 556 ][ 557 ][ 558 ][ 559 ][ 560 ]
[ 561 ][ 562 ][ 563 ][ 564 ][ 565 ][ 566 ][ 567 ][ 568 ][ 569 ][ 570 ]
[ 571 ][ 572 ][ 573 ][ 574 ][ 575 ][ 576 ][ 577 ][ 578 ][ 579 ][ 580 ]
[ 581 ][ 582 ][ 583 ][ 584 ][ 585 ][ 586 ][ 587 ][ 588 ][ 589 ][ 590 ]
[ 591 ][ 592 ][ 593 ][ 594 ][ 595 ][ 596 ][ 597 ][ 598 ][ 599 ][ 600 ]
[ 601 ][ 602 ][ 603 ][ 604 ][ 605 ][ 606 ][ 607 ][ 608 ][ 609 ][ 610 ]
[ 611 ][ 612 ][ 613 ][ 614 ][ 615 ][ 616 ][ 617 ][ 618 ][ 619 ][ 620 ]
[ 621 ][ 622 ][ 623 ][ 624 ][ 625 ][ 626 ][ 627 ][ 628 ][ 629 ] 
 
Magyar Dermatológiai Társulat
EADV face-to-face course: Skin Pigmentation in Universal Dermatology (Vilnius, Lithuania, 2025.02.10-11.)
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2025.02.10.Rendezvény vége: 2025.02.11.
Helyszín: Lithuania, Vilnius,
A rendezvény Web oldala: https://www.eadvlearning.org/learn/courses/306/skin-pigmentation-in-universal-dermatology-10-11-feb-2025-specialists
Specialists Course  

Program >> 

Course Description
Skin pigmentation is a major protective factor of human skin health. It is the most prominent phenotypic characteristic of humans. Its disorders can manifest as a wide spectrum of hyperpigmentation, hypopigmentation and depigmentation, including various benign and malignant skin diseases, which are common skin conditions diagnosed and treated by dermatologists. Protection against the harmful characteristic of ultraviolet radiation (UVR), which is a common skin ageing-inducing and carcinogenic factor, without skin pigmentation is impossible. In recent years, incredible progress has been made in understanding the regulation of human skin pigmentation and photo-ageing, the influence of different visible light spectrums, and the importance of UVR protection for pigmentary processes in the skin.

Pharmacological agents and cosmeceuticals, options of aesthetic medicine and LASER procedures to control skin pigment has been a goal in both the medical and cosmetic fields and has significant implications for skin cancer prevention, photoaging, and aesthetics. On the other hand, skin in colour and its diseases, which are phenotypically different than the known pictures in fair skin, currently, gains a great interest and the resulting knowledge invites dermatologists to become familiar with it. That is why it is necessary to delve into various aspects of human skin pigmentation, including its biochemical and hormonal control, response to UV, manifestations of skin pigmentation abnormalities, diseases and ageing, diagnostic techniques as well as pharmacological and interventional manipulations in both fair skin and skin of colour, in order to help patients as effectively as possible in daily dermatological practice

Learning Objectives
1. Basic understanding of melanocyte biology.
2. Basic and modern understanding of the pigmentation processes in human skin.
3. Clinical comprehension of dermatological pigmentary conditions, abnormalities and diseases.
4. Molecular aspects of pigmentary conditions, abnormalities and diseases.
5. Current pharmacological and interventional manipulations for the main pigmentary skin conditions, abnormalities and diseases.

Faculty
Chairs: Rūta Gancevičienė, Christos C. Zouboulis
Speakers: Carmen Salavastru, Mauro Picardo, Shyam Verma
Tutors: Tadas Raudonis, Agnė Sausdravė, Jorinta Jokubaitė

 
Magyar Dermatológiai Társulat
EADV face-to-face course: Skin Pigmentation in Universal Dermatology (Vilnius, Lithuania, 2025.02.10-11.)
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2025.02.10.Rendezvény vége: 2025.02.11.
Helyszín: Lithuania, Vilnius,
A rendezvény Web oldala: https://www.eadvlearning.org/learn/courses/306/skin-pigmentation-in-universal-dermatology-10-11-feb-2025-specialists
Specialists Course  

Program >> 

Course Description
Skin pigmentation is a major protective factor of human skin health. It is the most prominent phenotypic characteristic of humans. Its disorders can manifest as a wide spectrum of hyperpigmentation, hypopigmentation and depigmentation, including various benign and malignant skin diseases, which are common skin conditions diagnosed and treated by dermatologists. Protection against the harmful characteristic of ultraviolet radiation (UVR), which is a common skin ageing-inducing and carcinogenic factor, without skin pigmentation is impossible. In recent years, incredible progress has been made in understanding the regulation of human skin pigmentation and photo-ageing, the influence of different visible light spectrums, and the importance of UVR protection for pigmentary processes in the skin.

Pharmacological agents and cosmeceuticals, options of aesthetic medicine and LASER procedures to control skin pigment has been a goal in both the medical and cosmetic fields and has significant implications for skin cancer prevention, photoaging, and aesthetics. On the other hand, skin in colour and its diseases, which are phenotypically different than the known pictures in fair skin, currently, gains a great interest and the resulting knowledge invites dermatologists to become familiar with it. That is why it is necessary to delve into various aspects of human skin pigmentation, including its biochemical and hormonal control, response to UV, manifestations of skin pigmentation abnormalities, diseases and ageing, diagnostic techniques as well as pharmacological and interventional manipulations in both fair skin and skin of colour, in order to help patients as effectively as possible in daily dermatological practice

Learning Objectives
1. Basic understanding of melanocyte biology.
2. Basic and modern understanding of the pigmentation processes in human skin.
3. Clinical comprehension of dermatological pigmentary conditions, abnormalities and diseases.
4. Molecular aspects of pigmentary conditions, abnormalities and diseases.
5. Current pharmacological and interventional manipulations for the main pigmentary skin conditions, abnormalities and diseases.

Faculty
Chairs: Rūta Gancevičienė, Christos C. Zouboulis
Speakers: Carmen Salavastru, Mauro Picardo, Shyam Verma
Tutors: Tadas Raudonis, Agnė Sausdravė, Jorinta Jokubaitė

 
Magyar Gyermekorvosok Társasága
TREAT-NMD’s 8th International conference on translational medicine in inherited neuromuscular diseases (February 6th to 8th, 2025, Dubai)
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2025.02.06.Rendezvény vége: 2025.02.08.
Helyszín: Dubai,
A rendezvény Web oldala: https://www.treat-nmd.org/save-the-date-for-the-8th-treat-nmd-international-conference/
TREAT-NMD’s 8th International conference on translational medicine in inherited neuromuscular diseases runs from February 6th to 8th, 2025, in Dubai, with a key objective of sharing progress in translational medicine and plan for future therapies.
 
As part of the conference, we will be hosting a poster exhibition and would like to invite academics, researchers, patient organisations, advocates, industry, government agencies, and healthcare professionals to submit a poster abstract that will be displayed as part of the exhibition.
 
This is a prime opportunity to highlight the great work happening throughout the neuromuscular and rare disease community, as well as helping contribute to global advancements in healthcare.
 
Why Submit an Abstract?
 
Submitting an abstract and having it accepted for presentation at the conference offers you numerous advantages, including:
 
  • Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
  • Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
  • Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

 
What Are We Looking For?
 
This year’s poster topic is ‘Networking and Collaboration’ so we welcome abstract submissions centred on:
 
  1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
  2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
  3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

 
Submission Guidelines:
 
  •  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
  •  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
  • Abstracts should adhere to the specified format and guidelines provided on the conference website.

 
Deadline for Submissions:
 
The deadline for abstract submissions is 18th October 2024. Please ensure submissions are completed well in advance to allow for proper review and consideration. Notifications of acceptance will be sent out on 8th November 2024 after review by the Programme Committee.
 
How to Submit:
 
Abstracts can be submitted through the designated portal on the TREAT-NMD website. Detailed instructions and submission guidelines are available on the conference website here.
 
Join Us in Advancing Neuromuscular Care
 
We invite you to seize this opportunity to share your expertise, contribute to the collective knowledge, and help shape the future of neuromuscular healthcare worldwide. Together, we can make a difference in the lives of individuals affected by rare neuromuscular conditions.
 
We hope to see you in Dubai!
 
The TREAT-NMD Education and Events Team
 
Magyar Gyermekorvosok Társasága
TREAT-NMD’s 8th International conference on translational medicine in inherited neuromuscular diseases (February 6th to 8th, 2025, Dubai)
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2025.02.06.Rendezvény vége: 2025.02.08.
Helyszín: Dubai,
A rendezvény Web oldala: https://www.treat-nmd.org/save-the-date-for-the-8th-treat-nmd-international-conference/
TREAT-NMD’s 8th International conference on translational medicine in inherited neuromuscular diseases runs from February 6th to 8th, 2025, in Dubai, with a key objective of sharing progress in translational medicine and plan for future therapies.
 
As part of the conference, we will be hosting a poster exhibition and would like to invite academics, researchers, patient organisations, advocates, industry, government agencies, and healthcare professionals to submit a poster abstract that will be displayed as part of the exhibition.
 
This is a prime opportunity to highlight the great work happening throughout the neuromuscular and rare disease community, as well as helping contribute to global advancements in healthcare.
 
Why Submit an Abstract?
 
Submitting an abstract and having it accepted for presentation at the conference offers you numerous advantages, including:
 
  • Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
  • Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
  • Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

 
What Are We Looking For?
 
This year’s poster topic is ‘Networking and Collaboration’ so we welcome abstract submissions centred on:
 
  1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
  2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
  3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

 
Submission Guidelines:
 
  •  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
  •  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
  • Abstracts should adhere to the specified format and guidelines provided on the conference website.

 
Deadline for Submissions:
 
The deadline for abstract submissions is 18th October 2024. Please ensure submissions are completed well in advance to allow for proper review and consideration. Notifications of acceptance will be sent out on 8th November 2024 after review by the Programme Committee.
 
How to Submit:
 
Abstracts can be submitted through the designated portal on the TREAT-NMD website. Detailed instructions and submission guidelines are available on the conference website here.
 
Join Us in Advancing Neuromuscular Care
 
We invite you to seize this opportunity to share your expertise, contribute to the collective knowledge, and help shape the future of neuromuscular healthcare worldwide. Together, we can make a difference in the lives of individuals affected by rare neuromuscular conditions.
 
We hope to see you in Dubai!
 
The TREAT-NMD Education and Events Team
 
Magyar Gyermekorvosok Társasága
TREAT-NMD’s 8th International conference on translational medicine in inherited neuromuscular diseases (February 6th to 8th, 2025, Dubai)
Az ikonra kattintva az eseményt letöltheti a kalendárium programjába. (Például: Microsoft Outlook) Rendezvény kezdete: 2025.02.06.Rendezvény vége: 2025.02.08.
Helyszín: Dubai,
A rendezvény Web oldala: https://www.treat-nmd.org/save-the-date-for-the-8th-treat-nmd-international-conference/
TREAT-NMD’s 8th International conference on translational medicine in inherited neuromuscular diseases runs from February 6th to 8th, 2025, in Dubai, with a key objective of sharing progress in translational medicine and plan for future therapies.
 
As part of the conference, we will be hosting a poster exhibition and would like to invite academics, researchers, patient organisations, advocates, industry, government agencies, and healthcare professionals to submit a poster abstract that will be displayed as part of the exhibition.
 
This is a prime opportunity to highlight the great work happening throughout the neuromuscular and rare disease community, as well as helping contribute to global advancements in healthcare.
 
Why Submit an Abstract?
 
Submitting an abstract and having it accepted for presentation at the conference offers you numerous advantages, including:
 
  • Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
  • Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
  • Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

 
What Are We Looking For?
 
This year’s poster topic is ‘Networking and Collaboration’ so we welcome abstract submissions centred on:
 
  1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
  2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
  3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

 
Submission Guidelines:
 
  •  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
  •  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
  • Abstracts should adhere to the specified format and guidelines provided on the conference website.

 
Deadline for Submissions:
 
The deadline for abstract submissions is 18th October 2024. Please ensure submissions are completed well in advance to allow for proper review and consideration. Notifications of acceptance will be sent out on 8th November 2024 after review by the Programme Committee.
 
How to Submit:
 
Abstracts can be submitted through the designated portal on the TREAT-NMD website. Detailed instructions and submission guidelines are available on the conference website here.
 
Join Us in Advancing Neuromuscular Care
 
We invite you to seize this opportunity to share your expertise, contribute to the collective knowledge, and help shape the future of neuromuscular healthcare worldwide. Together, we can make a difference in the lives of individuals affected by rare neuromuscular conditions.
 
We hope to see you in Dubai!
 
The TREAT-NMD Education and Events Team
Aktuális kongresszusok, rendezvények megjelenítése >>


[ Vissza az előző oldalra ]

A Web-rendszerben található információk szolgáltatása és gyűjtése a magyar média és adatvédelmi törvények előírásait figyelembe véve történik.
A Web-rendszer teljes tartalmára minden jogot fenntartunk!
Copyright © 2025 doki.NET
Internet rendszerének szerkesztősége.


[ www.doki.NET ]